This Week in NEJM | GenomeWeb

This Week in NEJM

Premium

In NEJM this week, Schrappe et al. report on outcomes for children and adolescents with acute lymphoblastic leukemia, who suffer a failure of remission-induction therapy. The team identified induction failure by the persistence of leukemic blasts in blood, bone marrow, or any extramedullary site after treatment in 1,041 patients up to 18 years old.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.